Dublin, October 12, 2021/PRNewswire/-”Global Dermal Filler Market Forecast in 2028-COVID-19 Impact and Global Product Analysis (Biodegradable and Non-biodegradable); Materials; Applications; End Users and Geography “The report has been added to ResearchAndMarkets.com’s products.
By 2028, the market value of dermal fillers will increase from USD 4.39198 billion in 2021 to USD 9.421.3 billion; it is estimated that from 2021 to 2028, its compound annual growth rate is 11.5%. The growth of the dermal filler market is mainly attributed to the increasing preference for minimally invasive surgery, the growth of the population in the 30-65 age group, and consumers’ attractiveness to beauty and health. However, the high cost of surgery hinders the growth of the market. Dermal filler is an anti-aging product that is injected into the patient’s skin to increase volume. Inject them to make sagging skin or skin wrinkled by age look smooth and plump. They are also called injectable facial fillers, injectable cosmetic fillers or soft tissue fillers. They are made of hyaluronic acid derived from animal or patient fat. It takes five minutes to an hour to perform the dermal filler procedure. Intradermal fillers can be used in dermatological practice with minimal management costs. They solve the problems of facial volume loss and dynamic lines, which are the main signs of facial aging. They provide a range of flexible treatment options for dermatologists to achieve balanced and overall results. The dermal filler market has been segmented according to products, materials, applications, and end users. By product, the dermal filler market is divided into biodegradable and non-biodegradable. The biodegradable market segment is expected to occupy a larger market share in 2021, and is expected to record a higher compound annual growth rate during the forecast period. According to materials, the dermal filler market has been subdivided into calcium hydroxyapatite, hyaluronic acid, collagen, poly-L-lactic acid, polymethyl methacrylate (PMMA), fat and other materials. It is estimated that by 2021, the hyaluronic acid segment will occupy the largest market share, and the collagen segment is expected to have the highest compound annual growth rate during the forecast period.
According to the application, the dermal filler market has been subdivided into facial line correction treatment, lip enhancement, plastic surgery, scar treatment, etc. The facial line correction treatment segment is expected to occupy the largest market share in 2021, while the cosmetic surgery segment is expected to have the highest compound annual growth rate during the forecast period. According to end users, the dermal filler market has been subdivided into dermatology clinics, multi-specialty hospitals, and outpatient surgery centers. The dermatology clinic segment may occupy the largest market share in 2021. On the other hand, the multi-specialty hospital segment is expected to have the highest compound annual growth rate during the forecast period. Reason for purchase
By identifying the growth, size, leading players and market segments of the dermal fillers market, save and reduce the time to conduct entry-level research.
Highlight key business priorities to help the company realign its business strategy.
The main findings and recommendations highlight the key advancement industry trends in the global dermal filler market, thereby enabling participants across the value chain to formulate effective long-term strategies.
Formulate/modify business expansion plans by using substantial growth in developed and emerging markets.
In-depth review of global market trends and prospects, as well as the factors that drive the market and hinder market development.
Enhance the decision-making process by understanding the strategies that support the customer’s security interests in product, segmentation, pricing, and distribution.
Main topics covered: 1. Introduction 2. Dermal filler market-key point 3. Research method 4. Global Dermal Fillers Market-Market Landscape 4.1 Overview 4.2 PEST Analysis 4.2.1 North America-PEST Analysis 4.2.2 Europe-PEST Analysis 4.2.3 Asia Pacific-PEST Analysis 4.2.4 Middle East and Africa (MEA)-PEST Analysis 4.2.5 Southern and Central America (SCAM)-PEST Analysis4.3 expert opinion5. Dermal fillers market-key market dynamics 5.1 Market drivers 5.1.1 Increasing preference for minimally invasive surgery 5.1.2 Increasing population in the 30-65 age group 5.1.3 Increasing consumer attractiveness for beauty and health 5.2 Market restrictions 5.2.1 High-cost surgical procedures 5.3 Market opportunities 5.3.1 Increasing disposable income and expanding the middle-class population 5.4 Future trends 5.4.1 Strategic activities of market participants 5.4.2 Increasing adoption rate of injectable fillers in the male population 5.5 Impact analysis 6. Dermal filler market-global analysis 6.1 Global dermal filler market revenue forecast and analysis 6.2 Global dermal filler market, by geographic location-forecast and analysis 6.3 Market positioning 7. Dermal Filler Market Analysis-By Product 7.1 Overview 7.2 Dermal Filler Market Revenue Share By Product (2021 and 2028) 7.3 Biodegradable 7.3.1 Overview 7.3.2 Biodegradable: Dermal Filler Market-By 2028 Revenue and Forecast (Million USD) 7.4 Non-Biodegradable 7.4.1 Overview 7.4.2 Non-Biodegradable: Dermal Filler Market-Revenue and Forecast in 2028 (Million USD)8. Dermal Filler Market Analysis-8.1 Overview by Material 8.2 Dermal Filler Market Revenue Share by Material (2021 and 2028) 8.3 Calcium Hydroxyapatite 8.3.1 Overview 8.3.2 Calcium Hydroxyapatite: Dermal Filler Market-Revenue and Forecast to 2028 (Million USD) 8.4 Hyaluronic Acid 8.4.1 Overview 8.4.2 Hyaluronic Acid: Dermal Filler Market-Revenue and Forecast to 2028 (Million USD) 8.5 Collagen 8.5 .1 Overview 8.5.2 Collagen: Dermal Filler Market-Revenue and Forecast to 2028 (Million USD) 8.6 Poly-L-lactic Acid 8.6.1 Overview 8.6.2 Poly-L-Lactic Acid: Dermal Filler Market- Revenue and forecast to 2028 (million dollars) 8.7 Polymethyl methacrylate (PMMA) 8.7.1 Overview 8.7.2 Polymethyl methacrylate (PMMA): Dermal filler market-revenue and revenue by 2028 Forecast (US$ million) 8.8 Fat fillers 8.8.1 Overview 8.8.2 Fat fillers: dermal fillers market-revenue and forecast by 2028 (US$ million) 8.9 Other materials 8.9.1 Overview 8.9.2 Other materials : Dermal fillers market-revenue and forecast to 2028 (USD meters billion) 9. Dermal fillers market-by application 9.1 Overview 9.2 Dermal filler market share, by application, 2021 and 2028 (%) 9.3 Facial Line Correction Treatment 9.3.1 Overview 9.3.2 Facial Line Correction Treatment: Dermal Filler Market-Revenue and Forecast to 2028 (Million USD) 9.4 Lip Enlargement 9.4.1 Overview 9.4.2 Lip Enlargement: Dermal Filler Market-2028 Annual revenue and forecast (Millions of dollars) 9.5 Facial lift 9.5.1 Overview 9.5.2 Facial lift: Dermal filler market-Revenue and forecasts in 2028 (Millions of dollars) 9.6 Scar treatment 9.6.1 Overview 9.6.2 Scar Treatment: Dermal Filler Market-Revenue and Forecast in 2028 (Million USD) 9.7 Other Applications 9.7.1 Overview 9.7.2 Other Applications: Dermal Filler Market-Revenue and Forecast in 2028 (Million USD) 10. Dermal Fillers Drug Market-10.1 Overview by End User 10.2 Dermal Filler Market Share by End User, 2021 and 2028 (%) 10.3 Multi-specialty Hospital 10.3.1 Overview 10.3.2 Multi-specialty Hospital: Dermal Filler Market-By 2028 Revenue and Forecast (Million USD) 10.4 Dermatology Clinic 10.4.1 Overview 10.4.2 Dermatology Clinic: Dermal Filler Market-Revenue and Forecast in 2028 (Million USD) 10.5 Outpatient Surgery Center 10.5.1 Overview 10.5.2 Outpatient Surgery Center: Dermal Filler Market-Revenue and Forecast of USD 2028 (Million USD) 10.6 Other End Users 10.6.1 Overview 10.6.2 Other End Users: Dermal Filler Market-Revenue and Forecast by 2028 Forecast (Millions of USD) 11. Global Dermal Fillers Market-Geographical Analysis 12. Impact of the COVID-19 pandemic on the global dermal filler market 12.1 North America: Impact assessment of the COVID-19 pandemic 12.2 Europe: Impact assessment of the COVID-19 pandemic 12.3 Asia Pacific: Impact assessment of the COVID-19 pandemic 12.4 Middle East and Africa: Impact assessment of the COVID-19 pandemic 12.5 South and Central America: Impact assessment of the COVID-19 pandemic13. Dermal fillers market-industry landscape 13.1 Overview 13.2 Market growth strategy implemented by the company, (%) 13.3 Organic development 13.3.1 Overview 13.4 Inorganic development 13.4.1 Overview 14. Company Profile 14.1 AbbVie Inc. 14.1.1 Key facts 14.1.2 Business description 14.1.3 Products and services 14.1.4 Financial overview 14.1.5 SWOT analysis 14.1.6 Key developments 14.2 Galderma 14.2.1 Key facts 14.2.2 Products and services business Description 14.14.3 2.4 Financial overview 14.2.5 SWOT analysis 14.2.6 Key developments 14.3 Merz Pharma 14.3.1 Key facts 14.3.2 Business description 14.3.3 Products and services 14.3.4 Financial overview 14.3.5 SWOT analysis 14.3.6 Key developments 14.4 Suneva Medical 14.2s141 Key F14.214. Business Description 14.4.3 Products and Services 14.4.4 Financial Overview 14.4.5 SWOT Analysis 14.4.6 Key Development 14.5 BIOXIS Pharmaceutical 14.5.1 Key Facts 14.5.2 Business Description 14.5.3 Products And Services 14.5.4 Financial Overview 14.5.5 SWOT Analysis Key Development 14.5.6 Huadong Pharmaceutical Co., Ltd. 14.6.1 Main Overview 14.6.2 Business Description 14.6.3 Products and Services 14.6.4 Financial Overview 14.6.5 SWOT Analysis 14.6. 6 Major developments 14.7 Parkson Biotech Co., Ltd. 14.7.1 K All facts 14.7.2 Business description 14.7.3 Products and services 14.7.4 Financial overview 14.7.5 SWOT analysis 14.7.6 Key developments 14.8 TEOXANE laboratory 14.8.1 Key Facts 14.8.2 Business description 14.8.3 Products and services 14.8.85 Financial analysis 14.8.85 Financial analysis overview Main development 14.9 BIOHA laboratory 14.9.1 Main facts 14.9.2 Business description 14.9.3 Products and services 14.9.4 Financial overview 14.9.5 SWOT Analysis 14.9.6 Main Development 14.10 Prollenium Medical Technology 14.10.1 Main Facts 14.13.1 Products and Services 14.14.10 10.4 Financial Overview 14.10.5 SWOT Analysis 14.10.6 Main Development 15. Appendix For more information about this report, please visit https://www.researchandmarkets.com/r/fjwmol
Research and Marketing Laura Wood, Senior Manager press@researchandmarkets.com US Eastern Time Office hours call +1-917-300-0470 US/Canada toll free number +1-800-526-8630 GMT Office hours call +353-1 -416 -8900 US Fax: 646-607-1904 Fax (Outside the US): +353-1-481-1716
View the original text: https://www.prnewswire.com/news-releases/insights-on-the-dermal-fillers-global-market-to-2028—by-product-material-application-end-user- and -geography-301398176.html
Although the market is driven by short-term sentiment influenced by the loose interest rate environment in the United States, virus news and stimulus spending, many savvy investors have begun to be cautious about the current bull market since March 2020, hedging or reducing many of their long positions. Some fund managers bet on the Dow […]
For investors seeking the best return, the decision on where to invest their initial investment usually comes down to two options. Put all your eggs in a big basket, buy the big companies on the market, those trillion-dollar companies that are known for their high stock prices and steady growth-or buy low, and find a group of low-cost stocks in the company. Business foundation and huge upside potential. It all boils down to how much you want in return. Marketing
As basic companies make progress, smaller lithium stocks are attracting greater investor interest.
Apply for an American Express Platinum Card now and approve it before October 3, 2021, to enjoy an upgrade welcome offer and a HK5000 meal rebate upon sign-in and credit!
The dividend-paying stock portfolio provides the ballast for a rock-solid future and allows a small portion of your capital to be used for growth stocks and even higher-risk investments. In terms of sharing wealth with investors, Unilever (NYSE: UL), Altria Group (NYSE: MO), and Leggett (NYSE: LEG) are the blue-chip stocks one. For example, Unilever pays $2.02 per share per year, which means you need to buy 495 shares, and it will cost nearly $26,000 to purchase the stock at a stub price of more than $52.
Cowen Managing Director Kevin Kopelman joined Yahoo Finance to break down the unprecedented growth of Airbnb, which led to an upgrade of Cowen, the evidence supporting this upgrade, and the competitive state of the hotel industry.
Apply for the American Express Explorer™ Credit Card here to enjoy the first year fee and 3 times the pet-free points, smart shopping or offsetting different rewards for spending!
After Barclays analyst Kannan Venkateshwar maintained an equal weight rating on the stock and lowered its target price from $34 to $30, AT&T’s (NYSE: T) stock price fell on Monday. Barclays analysts pointed out that due to the challenging stock performance of Discovery Inc (NASDAQ: DISCA), AT&T will merge with its media business. At the time of launch, AT&T was one of the top three trending stocks on Stocktwits. AT&T will announce its third quarter financial results
Our three contributors provided three COVID-19 stocks, which will rise even if we emerge from the pandemic.
Apple’s iPhone production report caused futures to fall. Despite the strong actions taken by Upstart and more people, the market rebounded and closed poorly.
Selected customers apply for 12-36 repayment period and the amount is $200,000 or more, and an actual annual interest rate of 4% is set! Borrow to borrow? Also get a good loan!
ARK Invest continues to add some of the larger pendants of CEO Casey Wood, including pendants that have fallen nearly 60% since peaking in February.
The funny (or sad, depending on how you look at it) short stories from the past week will inspire you (hopefully) to double-check your portfolio as we enter 2022.
The mobile chip maker said its board of directors has approved a new $10 billion buyback program, which will take effect immediately.
From now until October 24, 2021, Ernst & Young’s large selection of items including household goods and women’s clothing will be offered at a discount of up to 20%, immediately launching favorite items!
A document shows that the combined dividend of the two independent companies will not be lower than the dividend before the split of IBM.
(Bloomberg)-Bloomberg reported that the technology giant may cut its 2021 iPhone 13 production target due to chip shortages, and quoted people familiar with the matter as saying that Apple’s suppliers fell on Wednesday. The humble roundabout became an art showcasing the front line of the abortion struggle in Kentucky, USA. It now looks like the Waldorf Astoria in New York undergoing luxurious renovations, becoming a symbol of the Chinese Overreach tycoon behind the real estate crash in the era of crisis.
After medical technologists raised their full-year financial forecasts, InMode (NASDAQ: INMD) shares rose 8.6% on Tuesday. Therefore, InMode expects revenue of $93 in the third quarter.
Online or physical professional teacher team, suitable for all professional enrollment, free cultural activities from time to time, experience different national customs, Prince Tuen Mun Yuen Long Tin Shui Wai Sha Tin Wind Class!
This biotech stock, which has only experienced volatility, is the favorite of retail investors because of the potential for short-squeeze.
Aadil Zaman, partner of the Wall Street Alliance Group, live broadcast on Yahoo Finance, discussing expectations for the third quarter earnings season, major banks and economic recovery.
Post time: Oct-13-2021